| Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: comparison of gene expression profiling approaches AK Turnbull, C Selli, C Martinez-Perez, A Fernando, L Renshaw, J Keys, ... BMC bioinformatics 21, 1-10, 2020 | 43 | 2020 |
| Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours C Selli, AK Turnbull, DA Pearce, A Li, A Fernando, J Wills, L Renshaw, ... Breast Cancer Research 21, 1-15, 2019 | 41 | 2019 |
| Macrophages promote anti-androgen resistance in prostate cancer bone disease XF Li, C Selli, HL Zhou, J Cao, S Wu, RY Ma, Y Lu, CB Zhang, B Xun, ... Journal of Experimental Medicine 220 (4), e20221007, 2023 | 29 | 2023 |
| Targeting cattle-borne zoonoses and cattle pathogens using a novel trypanosomatid-based delivery system GA Mott, R Wilson, A Fernando, A Robinson, P MacGregor, D Kennedy, ... PLoS pathogens 7 (10), e1002340, 2011 | 28 | 2011 |
| A test utilising diagnostic and on-treatment biomarkers to improve prediction of response to endocrine therapy in breast cancer. A Turnbull, Y Lee, D Pearce, C Martinez-Perez, S Uddin, H Webb, ... Journal of Clinical Oncology 34 (15_suppl), 555-555, 2016 | 3 | 2016 |
| Unlocking the transcriptomic potential of formalin-fixed paraffin embedded breast cancer tissues for high-throughput genomic analysis AK Turnbull, C Selli, C Martinez-Perez, A Fernando, L Renshaw, J Keys, ... Cancer Research 79 (4), 2019 | 2 | 2019 |
| EA2Clin: A novel immunohistochemical prognostic and predictive test for patients with estrogen receptor-Positive breast cancer AK Turnbull, A Fernando, L Renshaw, J Keys, JS Thomas, AH Sims, ... CANCER RESEARCH 78 (4), 2018 | 2 | 2018 |
| Abstract P3-10-26: Predicting benefit from HER2-targeted therapies in patients with ER+/HER2+ breast cancer AK Turnbull, V Webber, D McStay, L Arthur, C Martinez-Perez, ... Cancer Research 79 (4_Supplement), P3-10-26-P3-10-26, 2019 | 1 | 2019 |
| Abstract P5-11-02: Predicting local recurrence in patients treated for ductal carcinoma in situ of the breast (DCIS) C Martinez-Perez, AK Turnbull, GE Ekatah, LM Arthur, A Fernando, ... Cancer Research 78 (4_Supplement), P5-11-02-P5-11-02, 2018 | 1 | 2018 |
| Changes in ER pathway activity score during neoadjuvant letrozole to assess therapy response and predict disease free survival (DFS) in ER positive breast cancer patients AK Turnbull, MA Inda, A van de Stolpe, D Keizer, D Clout, H van Zon, ... Annals of Oncology 30, v95, 2019 | | 2019 |
| ER pathway activity score as a predictive biomarker to improve stratification for neoadjuvant endocrine therapy D Keizer, MA Inda, D Clout, A van de Stolpe, A Fernando, ... Annals of Oncology 30, iii16, 2019 | | 2019 |
| Abstract P5-04-03: Molecular characterisation of ER+ breast cancer dormancy and acquired resistance using a clinical model: Potential involvement of epigenetic regulation C Selli, AK Turnbull, D Pearce, A Fernando, L Renshaw, JS Thomas, ... Cancer Research 79 (4_Supplement), P5-04-03-P5-04-03, 2019 | | 2019 |
| Abstract P5-04-14: Tracking ESR1 mutation clonal evolution in breast cancer using in situ mutation detection C Martinez-Perez, AK Turnbull, M Tanioka, A Fernando, L Renshaw, ... Cancer Research 79 (4_Supplement), P5-04-14-P5-04-14, 2019 | | 2019 |
| Abstract P5-11-03: Measurement of on-treatment proliferation biomarkers in nodal metastasis improves prediction of endocrine therapy response using the EA2CliN test AK Turnbull, S Mok, C Martinez-Perez, A Fernando, L Renshaw, J Keys, ... Cancer Research 79 (4_Supplement), P5-11-03-P5-11-03, 2019 | | 2019 |
| Abstract P5-04-27: Investigating the incidence of ESR1 gene amplification in breast cancers resistant to multiple endocrine agents AK Turnbull, C Martinez-Perez, S Mok, M Tanioka, A Fernando, ... Cancer Research 79 (4_Supplement), P5-04-27-P5-04-27, 2019 | | 2019 |
| Abstract P3-06-17: Unlocking the transcriptomic potential of formalin-fixed paraffin embedded breast cancer tissues for high-throughput genomic analysis AK Turnbull, C Selli, C Martinez-Perez, A Fernando, L Renshaw, J Keys, ... Cancer Research 79 (4_Supplement), P3-06-17-P3-06-17, 2019 | | 2019 |
| Abstract P5-18-03: A predictive model for local recurrence in patients treated for ductal carcinoma in situ of the breast (DCIS) C Martinez-Perez, AK Turnbull, A Fernando, GE Ekatah, LM Arthur, ... Cancer Research 79 (4_Supplement), P5-18-03-P5-18-03, 2019 | | 2019 |
| Measurement of on-treatment proliferation biomarkers in nodal metastasis improves prediction of endocrine therapy response using the EA2CliN test AK Turnbull, S Mok, C Martinez-Perez, A Fernando, L Renshaw, J Keys, ... CANCER RESEARCH 79 (4), 2019 | | 2019 |
| Molecular characterisation of ER plus breast cancer dormancy and acquired resistance using a clinical model: Potential involvement of epigenetic regulation C Selli, AK Turnbull, D Pearce, A Fernando, L Renshaw, JS Thomas, ... CANCER RESEARCH 79 (4), 2019 | | 2019 |
| Abstract P4-08-02: Understanding the mechanisms of action underlying the role of IL6ST, a key biomarker for prediction of response to endocrine therapy AK Turnbull, A Fernando, C Martinez-Perez, AJ Finch, A von Kriegsheim, ... Cancer Research 78 (4_Supplement), P4-08-02-P4-08-02, 2018 | | 2018 |
